Search Results - christine+wei

2 Results Sort By:
Lipid Nanoparticle Formulations Capable of Migrating to Systemic Organs Following Intramuscular Administration
Value Proposition:Organ-targeted drug or mRNA delivery to focus therapy on specific tissues. Accessible intramuscular administration, offering broadly applicable, out-of-the-box drug delivery system for a range of therapeutics.Achieves organ-specific delivery without antibodies or targeting ligands, simplifying manufacturing and scalability.Unmet NeedTargeting...
Published: 9/12/2025   |   Inventor(s): Hai-Quan Mao, Yining Zhu, Christine Wei, Di Yu
Keywords(s):  
Category(s): Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
A mRNA Lipid Nanoparticle Incorporated Nanofiber-hydrogel Composite to Generate a Local Immunostimulatory Niche for Immunotherapy
Value Proposition:·        Creates a programmable immunostimulatory niche.·        Allows for tailor-made immune responses to vaccines and antigens.·        Flexible drug delivery platform enables mRNA therapeutics for infectious diseases and cancers.·        Applicable to existing mRNA vaccines for improved efficacy. ·        Can be utilized for novel...
Published: 9/12/2025   |   Inventor(s): Hai-Quan Mao, Yining Zhu, Jingyao Ma, Zhicheng Yao, Christine Wei
Keywords(s):  
Category(s): Clinical and Disease Specializations > Infectious Diseases, Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Research Tools, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Therapeutic Modalities > Vaccines, Technology Classifications > Research Tools > Microfluidics
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum